Domestic manufacturing and production of essential medicines, considering heavy reliance on China and other countries for API supplies, remains a hot topic in the US • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
